HRS-4642 Clinical Trials

3 actively recruiting trials

Pipeline

Phase 2: 1Phase 1/2: 2

Top Sponsors

Zhejiang University1
Jiangsu HengRui Medicine Co., Ltd.1
Fudan University1

Indications

Cancer3
Metastatic Pancreatic Carcinoma1
Pancreatic Cancer1
Advanced Solid Tumors1

Other3 trials

A Study of HRS-4642 in Combination With Antineoplastic Agents in Advanced Solid Tumors

Phase 1/2

Exploratory Clinical Study of HRS-4642 Combined With Adebelimab in the Treatment of Advanced Pancreatic Cancer

Phase 1/2

HRS-4642 With Nimotuzumab and Chemotherapy for First-line Treatment of Advanced Pancreatic Cancer Patients

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.